Slingshot AI vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
Slingshot AI raised $93M (a16z) for its Ash therapy chatbot with 50K beta users; withdrew from UK over medical device concerns while expanding US CBT-informed AI mental health access.
About
Slingshot AI is a mental health technology company developing AI-powered therapy and emotional support tools designed to expand access to mental health care. Backed by Andreessen Horowitz (a16z), Slingshot has built Ash, a conversational AI therapy chatbot that provides CBT-informed and evidence-based support to users between professional therapy sessions or as a standalone resource for people who cannot access or afford traditional therapy. The company was founded on the premise that the global mental health crisis — characterized by a severe shortage of therapists relative to need — requires AI-enabled solutions to close the access gap.\n\nAsh is designed to conduct structured therapeutic conversations, guide users through mental health exercises, track mood and symptom patterns over time, and provide crisis resources when needed. The platform is built with clinical input and aims to function at the boundary between a mental wellness app and a clinical-grade tool, offering more depth than meditation apps while being accessible without a prescription or insurance. Slingshot has enrolled 50,000+ beta users who have engaged with Ash's conversational therapy features across depression, anxiety, and stress-related concerns.\n\nSlingshot has raised $93M in total funding, backed by a16z and other investors, reflecting strong venture conviction in the mental health AI space despite a complex regulatory environment. The company made a notable decision to withdraw from the UK market in January 2026 over concerns about medical device regulatory requirements — the UK's MHRA was signaling that AI therapy tools would require medical device classification, raising the compliance burden significantly. This withdrawal highlights the tension between the consumer mental health app model and the regulatory frameworks emerging around AI clinical tools, a challenge Slingshot and the broader mental health AI category are actively navigating.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.